Name: Ana Catarina Fonseca
Task within EAN or at the congress: Portugal representative in the EAN Scientific panel on stroke
City, country: Lisbon, Portugal
Title of the Session: Presidential Symposium
Day, date and time of session: 20 June 2021 10:00 – 12:00
In the presidential symposium, we will have the opportunity to watch the lectures given by this year laureates. The lectures will be outstanding. Gabor Michael Halmagyi will address „Romberg and his famous test – what more do we know 170 years later“, Jean Claude Baron will talk about „The core/penumbra model: implications for acute stroke treatment and patient selection“ and Adriano Aguzzi will present the „History of prion science.“ . No one should miss these lectures.
Name: Ettore Beghi
Task within EAN or at the congress: Co-Chair, Epidemiology Panel; Member of the COVID-19 Task Force; Chair & speaker at the Career Development Session on Basic Statistics for Neurologists
City, country: Milano, Italy
Title of the Session: Etiology-driven therapy in epilepsy: From bedside to bench
Day, date and time of session: June 19, h 8:00-9:30
I have a personal scientific interest in epilepsy. Epilepsy is a heterogeneous clinical condition. The interplay between genetic background, structural lesions and other external causes is still ill-defined. Available antiseizure medications are purely symptomatic. Future treatments should be etiology-driven.
Name: Stefano F. Cappa
Task within EAN or at the congress: Speaker, Chairman
City, country: Milan, Italy
Title of the Session: Towards Precision Neurology, Plenary Symposium
Day, date and time of session: 21.6., 10 am
I am truly fascinated by the power of big data approaches and on the amazing number of successful applications that the new AI approaches are starting to have in the field of Neurology and Neuroscience.
Name: Gian Marco De Marchis, MD MSc FESO
Task within EAN or at the congress: Session Chair
City, country: Basel, Switzerland
Title of the Session: Secondary Stroke Prevention
Day, date and time of session: June 22, 2021 13:30-16:00
Preventing stroke from recurring is key. Strategies in secondary prevention increasing. The trend is towards personalized medicine. This session will focus on novel antithrombotic approaches, lipid-lowering strategies incl. PCSK9-inhibitors and treatment of cerebral vein thrombosis.
Name: Marianne de Visser
Task within EAN or at the congress: Co-chair Coordinating Panel on Rare Neurological diseases
City, country: Amsterdam, The Netherlands
Title of the Session: Presentation of The EAN Task Force on Gender and Diversity Issues in Neurology
Day, date and time of session: Sunday, 20 June, 12:30-13:00, Scientific Theatre
The European Academy of Neurology has recently established a Task Force on Gender and Diversity issues in Neurology. There is growing evidence that sex and gender differences are relevant in terms of epidemiology, clinical presentation, pathophysiology, management and outcomes of various neurological disorders. Epilepsy, migraine, stroke and ALS are diseases that immediately come to mind. One should be aware of these diversity issues because they may have great impact on management, clinical trials and prevention. However, this area is still underinvestigated and only partially known by neurologists and residents.
In the Scientific Theatre we will introduce the TF members and share the exciting activities that will be undertaken in the near future.
Name: Randi Eikeland
Task within EAN or at the congress: Speaker
City, country: Arendal, Norway
Title of the Session: MS related fatigue-tired of inflammation
Day, date and time of session: Sat 19 June, 08.00
As I am working with and doing reseach on neruoinfections and neurinflammation I am of cause very interested in fatigue!
Name: Elsa Azevedo
Task within EAN or at the congress: Member of the steering committee of Network of European Reference Centers in Neurosonology (ERNSono); Chair and Speaker of CBW5 EAN/ESNCH: Target clinical question, target neuro-pocus answer
City, country: Porto, Portugal
Title of the Session: CBW5 EAN/ESNCH: Target clinical question, target neuro-pocus answer
Day, date and time of session: June 2021 – 08:00 – 09:30
Neuro-POCUS (point of care ultrasound) gives us a unique opportunity of rapidly getting an answer to an important clinical question, just by immediately extending our arm through a probe until we enter the circulatory system and the nervous system. In this session we will show some of the applications of neuro-POCUS, such as how this precious complement of neurological assessment can help you to understand in the patient with acute stroke whether there is a large vessel occlusion, or if there is a > 50% carotid stenosis; in the emergency department, in a loss of vision case, if there is a central retina artery occlusion; in the neurocritical patient if there is intracranial hypertension; and, for example in the outpatient clinic, if in the case of a headache there is a giant-cell arteritis, or if in a case of pulsatile tinnitus there is a dural fistula.
These are just some examples of the many applications of neuro-POCUS. Jurgita Valaikienė, Elsa Azevedo and Piergiorgio Lochner are 3 neurologists and neurosonologists who will discuss how to approach with neuro-PoCUS the patient you are observing and treating, without the need to change for another place, and immediately getting answers that allow you to move forward more quickly treating the patient. This is a very appealing technique, particularly for young neurologists, and those in training, taking advantage of technology and the increasingly portable devices. So, we expect a very interesting and an as interactive as possible CbW, with a practical approach to the most updated point of care ultrasound to the neurological patient!
Name: Evangelos Anagnostou
Task within EAN or at the congress: Member of the Scientific Panel “Neuro-ophthalmology-Neuro-otology” , Speaker at the current congress in the Case-based Workshop “Diagnoses in neuro-ophthalmology you don’t want to miss”.
City, country: University of Athens , Greece
Title of the Session: Plenary Symposium, Gabor M Halmagyi “Moritz Romberg Lecture – Romberg and his famous test – what more do we know 170 years later”
Day, date and time of session: Sunday 20 June, 10:00-10:30
Bridging the gap between systems neurophysiology and clinical neurology has been always central in the field of eye movements and balance disorders. Michael Halmagyi is a prominent example of a clinician with a background in systems physiology, whose research on the vestibulo-ocular reflex led to the introduction of the famous head thrust test. I will not be missing this plenary lecture on Romberg’s test!
Name: Rolf Fronczek
Task within EAN or at the congress: Management team sleep panel & member headache panel, speaker at conference
City, country: Leiden, the Netherlands
Title of the Session: 5 Presidents Symposium Future of Sleep Medicine
Day, date and time of session: 19 June 2021 10:00 – 12:00
In this very unique symposium the presidents of five international sleep societies will give the latest updates about ‘the big five’: sleep apnea, narcolepsy, REM-sleep behaviour disorder, restless legs syndrome and new insights into REM-sleep regulation. This should be of interest to all neurologist who want to get ‘up to speed’ with the latest developments in sleep medicine. For a more basic, thorough introduction in sleep medicine, I would further advice the teaching course level 1 ‘Basics of Sleep Medicine’ on Saturday June 19 (15:00-18:15).
Name: Prof. Dr. Max J. HILZ, MD
Task within EAN or at the congress: Invited speaker
City, country: Erlangen,Germany & New York, NY; USA
Title of the Session: Symposium on “Brain-Heart Axis and Autonomic Dysfunction”
Day, date and time of session: June 22, 2021 from 13.00 h– 15.00h in “Main Auditorium”
Have you ever wondered why acute stroke patients suddenly develop cardiac complications, such as Takotsubo syndrome, arrythmias, myocardial infarction, or sudden death shortly after stroke onset? Did you know that persons who incurred a mild traumatic brain injury months or years ago are at increased risk of unexplained death? Do you wonder whether or how “Voodoo” death might come about during acute stress? Why don’t we faint while climbing up the stairs although the baroreflex should down-regulate increasing blood pressure? Can the heart compromise the brain?
These and other aspects of the brain-heart interaction will be addressed during the EAN Symposium on the “Brain-Heart Axis and Autonomic Dysfunction”. Autonomic nervous system experts like Jens Jordan, Director of the German Institute of Aerospace Medicine , Anne Pavy-LeTraon, and Constandina Arvanitis, an expert exploring the influence of the cardiovascular system on regulating brain structure and function, will highlight the reciprocal interactions between brain and heart.
The symposium covers issues that are poorly addressed during medical education and training although they are highly important for our daily work with patients. The symposium on the heart and brain interaction provides insights that will benefit the interaction with our patients.
Name: Prof. Jaroslaw Slawek, MD, PhD
Task within EAN or at the congress: President of Polish Neurological Society (delegate) and speaker at 7th EAN Congress
City, country: Gdansk, Poland
Title of the Session: EAN/MDS-ES Updates in Innovative Diagnostic Methods for Parkinson’s Disease and other Synucleinopathies
Day, date and time of session: Saturday 19th June, 2021
The progression of Parkinson’s Disease (PD) nowadays seems to be inevitable. The “Holy Graal” in PD and other neurodegenerations is the disease progression modulation to reach the milestones like fluctuations/dyskinesias, freezing of gait and dementia as late as possible and prolong the good quality of life. To reach this goal we need to understand the biology of the disease, biomarkers and mechanism of disease progression. This session will review all these topics which are crucial to identify patients at early stages and to understand if on-going clinical trials focused on alfa-synuclein removal are really promising for our patients.
Name: Regina Katzenschlager MD
Task within EAN or at the congress: Speaker
City, country: Vienna, Austria
Title of the Session: European Basal Ganglia Club
Day, date and time of session: Saturday 19th June 15:00 PM
I will not miss the sessions resulting from the cooperation between EAN and the International Parkinson and Movement Disorder Society (MDS). The European Basal Ganglia Club will provide clinically relevant videos of not-to-miss movement disorder diagnoses.”
Task within EAN or at the congress: Editor in chief of the European Journal of Neurology
City, country: Lille, France
Title of the Session: Highlight session
Day, date and time of session: June 22nd, 2021. 10:30 to 12:30
This session will underline what was new at the meeting. In 90 minutes you will have an excellent summary of the best of the 4 days.
Name: Flavio Nobili
Task within EAN or at the congress: co-chair of the Scientific Panel on Dementia and Cognitive Disorders
City, country: Genoa, Italy
Title of the Session: EAN/Euro-CNS Neuropathology of dementias: diagnosis at the microscope (Level 2)
Day, date and time of session: 21 June 2021 15:00 – 18:15
I have always considered our in vivo diagnoses as an approximation, maybe a good one but still an approximation. Comparing our diagnoses with post-mortem examination is paramount to understand if we are doing well and to improve our diagnostic power. In the field of dementia, co-pathologies are the rule rather than exception while in the current everyday work we tend to focus on a lone diagnosis. Too often post-mortem examinations are simply not performed and there is little contact between clinicians and pathologists, in most hospital realities. This must change in the next years and thus I wish to suggest everybody, especially the young neurologists, to attend this teaching session. Personally, I certainly will follow it!
Name: Anette Storstein
Task within EAN or at the congress: Chair, Scientific Panel of Neuro-oncology
Title of the Session: EAN/ISNI Immune checkpoint inhibitors: a step towards precision neurology
Day, date and time of session: 20 June 2021 08:00 – 09:30
Checkpoint inhibitors are one of the most exciting recent therapeutic developments in cancer therapy. However, the increasing use of these targeted treatments have also led to new insights in autoimmune neurological diseases, as well as new diagnostic and therapeutic dilemmas. Paraneoplastic neurological syndromes evolving after immune checkpoint inhibition and adverse events affecting the nervous system are by now highly relevant and important issues that should interest all neurologists. I really look forward to hear about this in the talk on neurological toxicity. I will also definitely not miss the two talks on potential therapeutic use of immune checkpoint inhibitors in infectious diseases of the CNS and in neuro-oncology.
Name: Dietmar Thal
Task within EAN or at the congress: Invited speaker
City, country: Leuven, Belgium
Title of the Session: Neuro-Covid across the continents
Day, date and time of session: Sat. 19 June 2021 15:00 – 16:30
For me it is essential to learn what consequences the COVID-19 pandemia may have for my future diagnostic work.